Health Minister Stephen Donnelly and Public Health Minister Frank Feighan have received government approval to implement additional restrictions on the sale and advertising of nicotine inhalation products such as e-cigarettes.
According to a new proposal, Ireland will ban the sale of e-cigarettes and related products in vending machines, temporary or mobile locations, and areas where children gather or activities take place. In addition, advertising of e-cigarettes will be prohibited near public transportation, movie theaters, and schools.
Donaldson stated, "These measures aim to protect our children and young people from starting to use e-cigarettes." "We recognize that nicotine is a highly addictive drug and today we are taking action to make it harder for young people to access these products and to remove advertisements for these products from our children's daily lives.
These proposals will be included in the current "Public Health (Tobacco and Nicotine Inhalation Product) Bill" that is being drafted. The bill is expected to be completed and published by the end of the year. The legislation will aim to regulate any product or ingredient that can be used to consume nicotine vapor.
The bill now includes provisions prohibiting the sale of nicotine inhalation products to individuals below the age of 18, and introduces licensing requirements for the retail of tobacco and nicotine inhalation products. Other measures included in the bill comprise:
Underage individuals are prohibited from selling tobacco and nicotine inhalation products. These products cannot be sold through vending machines, temporary or mobile devices, or at locations where children are present. Retailers who are convicted will face the shortest possible suspension period and a specified fine. Frank Feighan, the Minister of State responsible for public health, welfare, and national drug strategy, welcomed the government's approval of these measures.
In our country, smoking continues to cause approximately 4,500 deaths every year," he said. "We recognize that some adult smokers use nicotine inhalation products to help them quit smoking. However, we are well aware that these products have no benefits for our children, young people, or non-smokers, and that is why we are taking action today.
Statement:
This article is compiled from third-party information and is provided solely for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is solely for communication and research within the industry.
Due to limitations in translation abilities, this article may not fully convey the same message as the original. Please refer to the original text for accuracy.
Regarding any statements and positions related to domestic affairs, Hong Kong, Macau, Taiwan, or foreign affairs, 2FIRSTS agrees completely with the Chinese government.
The copyright of the compiled information belongs to the original media and author, and if there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
